CAT scan of brain, Alzheimer's disease (Credit: Getty Images)

Five ques­tions on the fu­ture of Lil­ly’s Alzheimer’s drug, from Dunn’s lega­cy to ARIA

Just days ago, suc­cess in Eli Lil­ly’s 30-year pur­suit of an Alzheimer’s dis­ease drug seemed all but guar­an­teed. Now, the FDA’s 11th …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.